Brain Tunnelgenix Technologies Corp. (BTT Corp) is engaged in the development of diagnostic and therapeutic technologies. The company's main products comprises of its Brain Temperature Tunnel product line, which includes Abreu BTT 700 system, Abreu-BTT continuous system-model 1000, Abreu-BTT spot check, BTT wireless devices and BTT intelligent eyewear. The products are in the pipeline and are to be launched in the market. The company's products find applications in the areas like medical, consumer, industrial, sports and hydration, industrial, and military markets. The company's technologies are protected through more than 60 patents and patent applications in the U.S. and in more than 40 other countries, and 85% of the world's purchasing power. Recently the FDA has approved its Abreu BTT 700 system. BTT Corp is based in Connecticut, the US.